Page 2616 - Markets News

Top trading ideas by Anand Rathi: Buy GSPL, Apollo Hospitals

Top trading ideas by Jay Anand Thakkar ,CMT -Assistant Vice President - Equity Research, Anand Rathi Shares and Stock Brokers

Market Ahead, July 16: Top factors that are likely to guide markets today

Investors may react primarily to June quarter earnings, global cues, and stock-specific action in today's trading session.

Nifty outlook and top stock picks by Prabhudas Lilladher: Buy TCS, Maruti

Nifty outlook and top trading ideas by Vaishali Parekh, research analyst - technical research at Prabhudas Lilladher.

A $677 billion fund manager spots buy opportunity amid India sell-off

Aberdeen Standard Investments Ltd manages $676.8 billion as of end-March, globally

Why is India trying to kill off the industry of domestic hedge funds?

By contrast, equity investment in India by overseas financial investors is upward of $400 billion

Investors flee debt funds as credit quality slumps to lowest in 16 months

Cracks in the money market that started with IL&FS Group's default last year widened in June after mortgage lender Dewan Housing Finance Ltd. delayed debt payments

Govt may issue sovereign bonds in phases, first lot to be of $3-4 billion

The bonds will likely be simultaneously launched in major financial centres such as London, Singapore, Hong Kong, New York and others

Securitisation market clocks 56% growth in Q1 despite liquidity crisis

In the June quarter of FY20, the securitisation volume stood at Rs 50,300 crore, as opposed to Rs 32,300 crore in the same quarter in the preceding financial year

11,450 key level for Nifty; investors may cut losses if market rises

Mid-caps and small-caps have lost more ground than the large-caps in the F&O sector

Sun Pharma bets on nurturing specialty portfolio outlook; stock rises 3.6%

Street is bullish on stabilising US generics sales, upsides from niche portfolio, and inexpensive valuations

Give priority to safety, do not chase high returns in company FDs

In the current stressed credit environment, give higher priority to safety of capital by sticking to the highest-rated instruments

Tech shares propel markets; Sensex up 160 pts, IndusInd Bank falls 2.4%

ICICI Bank, YES Bank, and State Bank of India - each declining a per cent

Life insurance can be a good investment bet in BFSI space, says expert

Strong individual business growth and market share gains are positives

Why analysts are positive on BEML stock despite muted Q1 expectations

The company is the largest beneficiary of government thrust on railway projects, particularly Metro rail

Market Wrap, July 15: Sensex gains 160 pts; broader markets underperform

Infosys reacted to the Q1FY20 results announced post market hours on Friday, with the stock rising over 7 per cent to close at Rs 779 levels on the NSE

MARKET WRAP: Sensex gains 160 pts; broader markets underperform, Infy up 7%

In the broader market, the S&P BSE MidCap settled 88 points, or 0.61 per cent, lower at 14,466 levels while the S&P BSE SmallCap closed 87 points, or 0.63 per cent, lower at 13,689 levels.

Infosys vs TCS: Which stock is a better bet at the current levels?

Post the results, most brokerages have revised their price targets for both these stocks.

Sun Pharma, Divi's Lab, Piramal Enterprises: Time to bet on pharma stocks?

A bullish divergence on RSI favours the upside momentum along with MACD, which is in a positive crossover

Sun Pharma gains for fifth straight day on Morgan Stanley's upgrade

In the past one week, Sun Pharma has outperformed the market by surging 16 per cent, as compared to 0.20 per cent decline in the S&P BSE Sensex

Five reasons why Morgan Stanley has turned bullish on Sun Pharma

The global brokerage firm said Sun Pharma was its top pick in its Indian healthcare coverage and sees 27 per cent upside potential in the stock